GLI3 and breast cancer: In addition, the absence of SMO expression was confirmed in seven cell lines, including five breast cancer cell lines and the stomach cancer AGS cell line, whereas the lack of SMO was accompanied by undetectable GLI3 in colon cancer HT29 cells.